A bill working its way through Congress could limit the advertising pharmaceutical companies can do directly to consumers. Advocates of the bill argue that such a restriction is necessary given the fact that too often drugs already on the market prove to be harmful to consumers. The proposed legislation would restrict drugs from being advertised for the first two years they are on the market. Of course, big pharma opposes the bill since it would severely hamper their profits. However, in the interest of consumer safety this looks like a very good idea that has been a long time in coming.
Comments are closed.